Chiou-Lian Lai Selected Research

Chiou-Lian Lai Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 11/2010
6	Cognitive Dysfunction 12/2021 - 06/2005
3	Dementia (Dementias) 08/2017 - 04/2012
2	Stroke (Strokes) 03/2022 - 06/2011
2	Obstructive Sleep Apnea 12/2018 - 10/2015
2	Hypertension (High Blood Pressure) 12/2015 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 01/2010
2	Hyperglycemia 04/2014 - 02/2010
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2014 - 07/2009
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 06/2005 - 05/2004
1	Atherosclerosis 03/2022
1	Myoclonus (Nocturnal Myoclonus) 03/2022
1	Hyperalgesia 12/2020
1	Neuroinflammatory Diseases 12/2020
1	Pain (Aches) 12/2020
1	Fibromyalgia (Fibrositis) 12/2020
1	Infections 09/2020
1	Pneumonia (Pneumonitis) 09/2020
1	Apnea 10/2015
1	Language Disorders (Language Disorder) 04/2014
1	Diplopia (Double Vision) 01/2014
1	Diabetes Mellitus 01/2013
1	Atrial Fibrillation 01/2013
1	Hyperlipidemias (Hyperlipidemia) 01/2013
1	Tuberculoma 07/2012
1	Paralysis (Palsy) 06/2011
1	Dyspnea (Shortness of Breath) 06/2011
1	Major Depressive Disorder (Major Depressive Disorders) 11/2010
1	Kleine-Levin Syndrome (Syndrome, Kleine-Levin) 06/2010
1	Hallucinations (Hallucination) 06/2010
1	Demyelinating Diseases (Demyelinating Disease) 07/2009
1	Hemorrhage 01/2008
1	Thrombocytopenia (Thrombopenia) 01/2008
1	Ischemic Stroke 10/2007
1	Myopathy with Abnormal Lipid Metabolism 09/2004
1	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 09/2004
1	Vacuolar myopathy 09/2004
1	Pancreatitis 09/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2004

Drug/Important Bio-Agent (IBA)

5	ApolipoproteinsIBA 01/2019 - 05/2004
4	Apolipoproteins E (ApoE)IBA 07/2014 - 05/2004
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2015 - 03/2011
2	Cytochrome P450 Family 46 (CYP46)IBA 07/2014 - 11/2011
2	Donepezil (Aricept)FDA LinkGeneric 01/2013 - 01/2011
2	Indicators and Reagents (Reagents)IBA 01/2013 - 10/2006
1	Antirheumatic Agents (DMARD)IBA 03/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2022
1	AutoantigensIBA 12/2020
1	Biological ProductsIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2020
1	darapladibIBA 12/2020
1	Acid Sensing Ion ChannelsIBA 12/2020
1	AntioxidantsIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	Transcription Factors (Transcription Factor)IBA 02/2019
1	oxidized low density lipoproteinIBA 08/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2017
1	A-factor (Streptomyces)IBA 08/2017
1	Rivastigmine (Exelon)FDA LinkGeneric 06/2017
1	Fumigant 93 (D-D)IBA 12/2015
1	Oxygen (Dioxygen)IBA 10/2015
1	Carbamazepine (Tegretol)FDA LinkGeneric 04/2014
1	GlucocorticoidsIBA 01/2014
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2013
1	CholesterolIBA 11/2011
1	danaparoid (Orgaran)FDA Link 06/2011
1	Blood Proteins (Serum Proteins)IBA 03/2011
1	Biomarkers (Surrogate Marker)IBA 03/2011
1	HomocysteineIBA 11/2010
1	Modafinil (Provigil)FDA Link 06/2010
1	Blood Glucose (Blood Sugar)IBA 02/2010
1	Apolipoprotein E4IBA 01/2010
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 07/2009
1	Nerve Growth Factors (Neurotrophins)IBA 07/2009
1	NeuropeptidesIBA 07/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2008
1	Immunologic Factors (Immunomodulators)IBA 01/2008
1	LipidsIBA 09/2004
1	Riboflavin (Vitamin B2)FDA LinkGeneric 09/2004
1	Carnitine (L-Carnitine)FDA LinkGeneric 09/2004
1	AcidsIBA 09/2004

Therapy/Procedure

3	Therapeutics 12/2018 - 07/2012
1	Lasers (Laser) 12/2021
1	Continuous Positive Airway Pressure 12/2018
1	Music Therapy 01/2015
1	Transcranial Magnetic Stimulation 06/2011
1	Institutionalization (Institutionalized Persons) 06/2005